Skip to content

Long-Term Mortality Impacts of COVID-19

6/9/2021 11:00 AM - 12:00
Webinar

Overview

Who Should Watch

  • Product Development/Pricing/Underwriting & Claims professionals in the supplemental benefits sector including; critical illness, hospital indemnity, Medicare supplement, disability, long-term care, etc.
  • Chief Actuaries (Product Development & Pricing), Risk Managers, Chief Financial Officers, Underwriters, and Medical Directors of all life carriers.
  • Workplace benefits market and product leaders

This is a LIMRA/LOMA Member Benefit webinar.

Highlights

If the current pandemic is a series of waves, the long-term effects could be a tsunami. With attention focused on vaccine distribution and controlling the current surge in cases, more consideration must be given to the shape of COVID-19 in 2021, 2022, and beyond. Millions who have already had the virus are dealing with lingering symptoms and chronic effects, so it’s imperative that we address the long-term impact of COVID on healthcare and mortality.

Join us as our special guest Swiss Re's Dr. Elyssa Del Valle, Chief Medical Officer, Life & Health Americas; Dr. Christoph Nabholz, Head of Research Engagement, Swiss Re Institute, and Dr. Daniel Zamarripa, Chief Medical Officer, AIG for an informative, virtual discussion on the long-term impacts of COVID and what it means for insurers.

Presenters

Dr. Elyssa Del Valle
Chief Medical Officer, Life & Health Americas, Swiss Re

Dr. Elyssa Del Valle

Chief Medical Officer, Life & Health Americas, Swiss Re

Dr. Christoph Nabholz
Head of Research Engagement, Swiss Re Institute

Dr. Christoph Nabholz

Head of Research Engagement, Swiss Re Institute

Dr. Daniel Zamarripa
Chief Medical Officer, AIG

Dr. Daniel Zamarripa

Chief Medical Officer, AIG

Contact us to learn more:

Amanda Cristina

Senior Meeting Planner

LIMRA

(860) 298-3829

acristina@limra.com